openPR Logo
Press release

Global Cancer Nanomedicine Market & Cancer Nanomedicine Clinical Trials Outlook 2022

07-07-2017 08:54 AM CET | Health & Medicine

Press release from: Kuick Resarch

Global Cancer Nanomedicine Market & Cancer Nanomedicine

Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, very recent breakthroughs in nanomedicine have managed to change all that. Now at last there is hope for a cure that is effective and can be made it safe.

Indeed, there is still plenty of work to be done, some very promising new nanomedicine treatment methods are in the works. Nanomedicine treatments can be used in both the preventive and in the therapeutic approaches to deal with cancer. With better knowledge researchers are able to engineer more sophisticated nanodevices and to equip them with effective targeting techniques for biomolecules; will gain the ability to treat various kinds of cancer more and more effectively.

The future of cancer nanotechnology lies on a multifunctional nanoplatform that combines both therapeutic components and multimodality imaging. The ultimate goal is that multifunctional nanomedicine works as efficient, targeted in vivo drug delivery without systemic toxicity, and the dose delivered as well as the therapeutic efficacy can be accurately measured noninvasively with time.

Diagnosis and therapy combined in one system is the current advanced biomedical tool referred to as theragnostics. The primary goal of theragnostics is to selectively target the disease confined to tissue/cell in order to increase diagnostic and therapeutic selectivity that makes the treatment shorter, safer, effective and inexpensive. Biocompatible/biodegradable nanocarriers are currently under development in oncological theragnostics that would enable precise diagnosis and therapy.

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

Download Report: https://www.kuickresearch.com/report-global-cancer-nanomedicine-market-outlook-2022.php

Report Table of Contents

Cancer Nanomedicine: An Optimistic Avenue
1.1 Introduction
1.2 Emergence of Nanomedicines

Prerequisite of Nanomedicines
2.1 Conventional Cancer Treating Approaches
2.2 Nanomedicines: Overcoming the Hurdles

Diversification of Nanomedicines
3.1 Classification on Basis of Constituents
3.1.1 Inorganic Nanoparticles
3.1.2 Organic Nanoparticles
3.2 Classification on Basis of Applicability
3.2.1 Nanomedicine as Diagnostic Agents
3.2.2 Nanomedicine as Therapeutic Agents
3.2.3 Nanomedicine as Drug Delivery Agents
3.3 Classification on Basis of Dimensions

Mechanism of Action of Nanomedicine
4.1 Targeting Tumor Cells
4.1.1 Passive Targeting
4.1.2 Active Targeting
4.2 Nanocarrier - Drug Complex
4.2.1 Liposomes
4.2.2 Dendrimers
4.2.3 Micelles
4.2.4 Inorganic Nanocarriers
4.3 Drug Release Systems

Nanomedicine Engineering: Design and Strategy
5.1 Organic Nanoparticles as Nanomedicines
5.1.1 Polymeric Nanoparticle
5.1.2 Lipid Organic Nanoparticles
5.2 Inorganic Nanoparticles as Nanomedicines
5.2.1 Synthesis of Gold Nanoparticle

Cancer Nanomedicine as Diagnostic Tool
6.1 Detection of Cancer Biomarkers
6.1.1 Detection of Circulating Tumor Cell
6.2 Diagnostic Device and Nanoprobes
6.2.1 Biosensors
6.2.2 Microarrays
6.3 Quantum Dots for Early Cancer Detection
6.3.1 Detection of primary Cancers
6.3.2 Quantum Dots for Tumor Imaging

Cancer Therapeutics with Nanomedicines
7.1 Nanomedicine as Therapeutic Agents
7.1.1 Photodynamic Therapy
7.1.2 Photo Thermal Therapy
7.2 Nanomedicines as Prophylactic and Therapeutic Approach
7.2.1 Cancer Cell Destruction
7.3 Nanomedicine in Breast Cancer
7.4 Nanomedicine in Pancreatic Cancer
7.5 Nanomedicine in Brain Cancer
7.6 Nanomedicine in Lung Cancer

Cancer Imaging with Nanomedicine
8.1 Positron Emission Tomography
8.1.1 Applications in various Cancers
8.2 Single Photon Emitted Tomography
8.2.1 Computed Tomography
8.3 Magnetic Resonance Imaging (MRI)
8.3.1 Optical Imaging

Drug Delivery with Nanomedicines
9.1 Nanocarrier and Chemotherapy
9.1.1 Peptide Nanomedicine- An Example of Nanocarrier Chemotherapy
9.2 Nanomedicine Endocytosis and Intracellular Mechanisms
9.3 Factors Affecting Drug Delivery

Global Cancer Nanomedicine Market Overview
10.1 Current Market Scenario
10.2 Global Cancer Nanomedicine Clinical Pipeline Overview

Global Nanomedicine Market Dynamics
11.1 Encouraging Market Aspects
11.2 Commercialization Challenges

Global Cancer Nanomedicine Future Prospect

Global Cancer Nanomedicine Clinical Pipeline by Company, Indication and Phase
13.1 Research
13.2 Preclinical
13.3 Phase-I
13.4 Phase-I/II
13.5 Phase-II
13.6 Phase-III

Marketed Cancer Nanomedicine Clinical Insight by Company, Indication and Phase
14.1 Caelyx and Doxil
14.2 Albumin-Bound Paclitaxel (Abraxane and Coraxane)
14.3 Nilotinib (Tasigna)
14.4 Paclitaxel Polymeric Micelle Formulation (Cynviloq and Genexol-PM)
14.5 Paclitaxel Liposomal
14.6 Vincristine Liposomal (Marqibo)
14.7 Rexin-G
14.8 Paclitaxel Nanoparticle (Nanoxel)

Competitive Landscape
15.1 Abraxis BioScience
15.2 Access Pharmaceuticals
15.3 Alnylam Pharmaceuticals
15.4 Amgen
15.5 Arrowhead Research
15.6 BIND Therapeutics
15.7 Cadila Healthcare
15.8 Celegen Corporation
15.9 Celsion Corporation
15.10 Genzyme Corporation
15.11 Merck
15.12 NanoCarrier
15.13 Nippon Kayaku
15.14 Nanobiotix
15.15 Novavax
15.16 Pfizer
15.17 Roche
15.18 Samyang
15.19 Sanofi
15.20 Takeda Pharmaceutical

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cancer Nanomedicine Market & Cancer Nanomedicine Clinical Trials Outlook 2022 here

News-ID: 613348 • Views: 269

More Releases from Kuick Resarch

Growing Opportunity with Saudi Arabia Diabetes Market
Among all the developed countries of Middle East, the country that is showing maximum trends and opportunities with respect to diabetes market is Saudi Arabia. With the urbanization and industrial development in the country, the population of Saudi Arabia has shown tremendous economic shift which has resulted in the influx of several kinds of diseases that were not observed in the country few years back. The momentum that the population
Cancer Tumor Organoid Modifying the Overall Cancer Market Scenario
Within no time, the organoid cultures for cancer treatment have emerged as one of the most powerful modeling system in the field of cancer biology. From the very beginning of the market, it has been experiencing high adoption rate among the researchers and patients, minimum side effects and maximum appreciation for being unique among all the other 2-D model systems available in the market. The arrival of cancer organoids by
Personalized Cancer Vaccine – A Novel Treatment for Poor Cancer Survival Rate
The ongoing clinical advancement that is represented by the personalized cancer vaccine is helping to identify the applications of vaccine across the multiple cancers. The development of novel cancer vaccines for the cancer treatment has transformed the overall and widespread adoption of the vaccines in the research community. An important factor that is promoting the growth of the vaccines in oncology research world is that it is shows significant potential
Small Molecule Cancer Drugs Drastically Improves the Cancer Survival
Small molecule drugs, which attack the cancer cells has been used to treat many different types of cancer with remarkable success every time. In the research field, the increase in the mortality of cancer has been majorly contributed by some of the treatment regimens that have an unwanted gesture against the cancer cells. The presence of non-specific cancer treatments such as chemotherapy or radiation therapy have made the study of

All 5 Releases


More Releases for Nanomedicine

Global Cancer Nanomedicine Market Outlook 2022 Report
“Global Cancer Nanomedicine Market Outlook 2022” Report Highlights: * Overview and Mechanism of Action of Nanomedicine * Nanomedicine Engineering: Design and Strategy * Cancer Nanomedicine as Diagnostic and Therapeutics Tool * Global Cancer Nanomedicine Market Overview and Dynamics * Global Cancer Nanomedicine Clinical Pipeline by Company, Indication and Phase * Global Cancer Nanomedicine Clinical Pipeline: 124 Drug * Marketed Cancer Nanomedicine: 8 Drugs Download Report Sample Weblink: https://www.kuickresearch.com/report-global-cancer-nanomedicine-market-outlook-2022.php For Report Sample Contact: neeraj@kuickresearch.com Table of Contents Cancer Nanomedicine:
Global Nanomedicine Market $185 Billion by 2021
The global nanomedicine market is estimated to reach $185 Billion in 2021, growing at a CAGR of 8.9% from 2017 to 2021, according to a market research report Nanomedicine Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc. Visit the Nanomedicine Market Analysis and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/nanomedicine-market/ Nanomedicine is the medical application of nanotechnology that ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and
Cancer Nanomedicine Market Cancer Nanomedicine Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Cancer Nanomedicine: An Optimistic Avenue 1.1 Introduction 1.2 Emergence of Nanomedicines Prerequisite of Nanomedicines 2.1 Conventional Cancer Treating Approaches 2.2 Nanomedicines: Overcoming the Hurdles Diversification of Nanomedicines 3.1 Classification on Basis of Constituents 3.1.1 Inorganic Nanoparticles 3.1.2 Organic Nanoparticles 3.2 Classification on Basis of Applicability 3.2.1
Global Nanomedicine Market & Pipeline Insight 2015
Nanomedicines or nanotherapeutics is an emerging field in which nanotechnology principles are used to design and develop better therapeutics having high safety and efficacy profiles. It is a multidisciplinary approach utilizing knowledge from allied fields like biotechnology and pharmacology in drug development program. Novel modalities for cancer treatment, targeted drug delivery, biosensors, imaging, delivery vehicles and diagnostic methods are being actively investigated by pharmaceutical companies. They have been widely accepted
Global Cancer Nanomedicine Market Outlook 2022
Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, recent breakthroughs in nanomedicine have managed
Global Cancer Nanomedicine Market Outlook 2022
Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, recent breakthroughs in nanomedicine have managed